Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

141 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Active, not recruiting

SP Thoracic IDE Study

NCT05150210

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Benign Lung Disease, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

NCT06298552

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +13 more
Locations
  • HonorHealth Neurology - Bob Bove Neuroscience Institute Scottsdale, Arizona, United States
  • Loma Linda University Health Fresno, California, United States
  • First Choice Neurology Boca Raton Boca Raton, Florida, United States
  • SFM Clinical Research LLC Boca Raton, Florida, United States
View all 91 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Local Institution - 0011 Birmingham, Alabama, United States
  • University of California, Irvine Irvine, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 34 locations
View Trial Details
Active, not recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

NCT06106672

Conditions
AChR Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Infusion for Health Brea, California, United States
  • University of California, Irvine Orange, California, United States
  • University of California, Davis Sacramento, California, United States
View all 17 locations
View Trial Details

Related conditions